Fig. 1From: Higher locoregional recurrence rate for triple-negative breast cancer following neoadjuvant chemotherapy, surgery and radiotherapyComparisons of survivals between subtypes in non-pCR patients. a Locoregional-recurrence-free survival (LRR-Free Survival). b Distant-metastasis-free survival (DM-Free Survival). c Progress-free survival. d Overall survival. P values shown here are from comparisons among all three subtypes.Back to article page